News

The agreement granted Takeda exclusive rights to market ferumoxytol in Canada, EU and Switzerland, as well as certain other geographic territories As part of the termination deal, AMAG

The drug is indicated for use in adults to manage pain, by taking it alone or in combination with opioid analgesics. Hospira senior vice-president and chief scientific officer

FDA has approved the new drug application (NDA) for Namzaric to treat moderate to severe dementia of the Alzheimer’s type in patients stabilised on memantine hydrochloride and donepezil

After securing clinical trial application (CTA) regulatory approval, the company plans to conduct a Phase I trial to assess the safety, tolerability and dose escalation of Anatabine Citrate

The grant award will assist with advancing an SVP cancer immunotherapy from preclinical through early clinical evaluation. This immuno-oncology program is designed to develop novel SVP immunotherapies capable

With the approval of this additional administration option, physicians will soon have the flexibility to prescribe GRANIX for either in-office or at home use. GRANIX, a leukocyte growth

Rosacea is a common, but often misunderstood, skin disorder affecting 16 million Americans,predominantly women, ages 30 and older. Although the cause of rosacea is unknown, research suggests that

SB742457 has shown promise for patients with mild-to-moderate Alzheimer’s disease in 13 clinical studies conducted to date by GSK using more than 1,250 healthy subjects and Alzheimer’s disease

This action allows for the initiation of clinical trials, which ContraFect expects to commence in Q1 2015. Julia P. Gregory, ContraFect’s chief executive officer commented, "CF-301 will be